• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Proteome Res . Ubiquitin-Modified Proteome of SARS-CoV-2-Infected Host Cells Reveals Insights into Virus-Host Interaction and Pathogenesis

tetano

Editor, Senior Moderator
J Proteome Res


. 2021 Mar 5.
doi: 10.1021/acs.jproteome.0c00758. Online ahead of print.
Ubiquitin-Modified Proteome of SARS-CoV-2-Infected Host Cells Reveals Insights into Virus-Host Interaction and Pathogenesis


Huan Zhang[SUP] 1 [/SUP], Huanying Zheng[SUP] 2 [/SUP], Jinying Zhu[SUP] 1 [/SUP], Qiao Dong[SUP] 1 [/SUP], Jin Wang[SUP] 3 [/SUP], Huahao Fan[SUP] 4 [/SUP], Yangzhen Chen[SUP] 4 [/SUP], Xi Zhang[SUP] 1 [/SUP], Xiaohu Han[SUP] 1 [/SUP], Qianlin Li[SUP] 3 [/SUP], Jiahai Lu[SUP] 3 [/SUP], Yigang Tong[SUP] 4 [/SUP], Zeliang Chen[SUP] 1 3 4 [/SUP]



Affiliations

Abstract

The outbreak of coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has posed a serious threat to global public health. The mechanism of pathogenesis and the host immune response to SARS-CoV-2 infection are largely unknown. In the present study, we applied a quantitative proteomic technology to identify and quantify the ubiquitination changes that occur in both the virus and the Vero E6 cells during SARS-CoV-2 infection. By applying label-free, quantitative liquid chromatography with tandem mass spectrometry proteomics, 8943 lysine ubiquitination sites on 3086 proteins were identified, of which 138 sites on 104 proteins were quantified as significantly upregulated, while 828 sites on 447 proteins were downregulated at 72 h post-infection. Bioinformatics analysis suggested that SARS-CoV-2 infection might modulate host immune responses through the ubiquitination of important proteins, including USP5, IQGAP1, TRIM28, and Hsp90. Ubiquitination modification was also observed on 11 SAR-CoV-2 proteins, including proteins involved in virus replication and inhibition of the host innate immune response. Our study provides new insights into the interaction between SARS-CoV-2 and the host as well as potential targets for the prevention and treatment of COVID-19.

Keywords: LC-MS; coronavirus disease 2019; severe acute respiratory syndrome coronavirus 2; ubiquitome.
 
Back
Top Bottom